Fluzone High-Dose Quadrivalent
Details for Fluzone High-Dose Quadrivalent vaccine and its components.
Sponsor:
Sanofi-Aventis Australia
Administration route:
Intramuscular injection
Vaccine group:
Adults aged ≥60 years only
Registered for use in people aged ≥60 years.
Quadrivalent inactivated influenza vaccine, split virion.
Each 0.7 mL monodose pre-filled syringe contains:
- 60 µg haemagglutinin of each of the 4 recommended influenza virus strains
- sodium chloride
- dibasic sodium phosphate
- monobasic sodium phosphate
- octoxinol-9
- water
May contain traces of:
- ≤ 140 µg formaldehyde
- ≤ 1 µg ovalbumin
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
Page history
Last updated:
21 April 2022
Last reviewed:
21 April 2022
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/fluzone-high-dose-quadrivalent.